Search results for: “Moderna”
-
Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery
Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells.
-
Moderna to Build mRNA Vaccine Plant in Canada
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada.
-
Moderna Expands Vaccine Research, Mfring in Asia
Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea.
-
Moderna Supplying 500M Vaccine Doses to Covax
Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries.
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.
-
Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.
-
Moderna Funding University Immunology Research
A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders.
-
Moderna, Merck Partner on Personal Cancer Vaccines
29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 million, and the chance to earn further payments to develop cancer treatments combining Moderna’s technology with an…
-
A Good Run
After 13 and a half years, the intersection of science and business remains a compelling subject, but there are other things I now want to do, and it’s time to bring Science & Enterprise to a close.
-
Trial Set to Test Inhaled mRNA for Viral Infections
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.